Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,266 INR | +5.72% | +3.94% | +16.87% |
03:59am | Hindalco-owned Novelis delays US IPO; shares slide | RE |
May. 27 | Aurobindo Pharma Clocks Gains in Fiscal Q4 Consolidated Net Profit | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.87% | 8.4B | |
+42.83% | 750B | |
+34.11% | 606B | |
-5.70% | 356B | |
+18.06% | 326B | |
+4.63% | 286B | |
+17.94% | 246B | |
+10.85% | 213B | |
-2.99% | 213B | |
+2.43% | 167B |
- Stock Market
- Equities
- AUROPHARMA Stock
- News Aurobindo Pharma
- Transcript : Aurobindo Pharma Limited, Q4 2023 Earnings Call, May 29, 2023